Journal of Surgical Research
Volume 155, Issue 2 , Pages 217-224 , August 2009

Escherichia coli and TNF-α Modulate Macrophage Phagocytosis of Candida glabrata1

  • Donavon J. Hess, M.D., Ph.D.

      Affiliations

    • Department of Surgery, University of Minnesota, Minneapolis, Minnesota
    • ,
  • Michelle J. Henry-Stanley, Ph.D.

      Affiliations

    • Department Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota
    • ,
  • Catherine M. Bendel, M.D.

      Affiliations

    • Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota
    • ,
  • Bin Zhang, M.D., Ph.D.

      Affiliations

    • Department Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota
    • ,
  • Mary-Alice Johnson, M.D.

      Affiliations

    • Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota
    • ,
  • Carol L. Wells, Ph.D.

      Affiliations

    • Department of Surgery, University of Minnesota, Minneapolis, Minnesota
    • Department Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at the Department of Laboratory Medicine and Pathology, Mayo Mail Code 609, University of Minnesota, Minneapolis

Received 7 January 2008

References 

  1. Rangel-Frausto M, Wiblin T, Blumberg HM, et al. National epidemiology of mycoses survey (NEMIS): Variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis. 1999;29:253
  2. Pappas PG, Rex JH, Lee J, et al. A perspective observational study of candidemia: Epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis. 2003;37:634
  3. Charles PE, Doise JM, Quenot JP, et al. Candidemia in critically ill patients: Difference of outcome between medical and surgical patients. Intensive Care Med. 2003;29:2162
  4. Peres-Bota D, Rodriguez-Villalobos H, Dimopoulos G, et al. Potential risk factors for infection with Candida spp. in critically ill patients. Clin Microbiol Infect. 2004;10:550
  5. Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial blood stream infections in U.S. hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309
  6. Snydman DR. Shifting patterns in the epidemiology of nosocomial Candida infections. Chest. 2003;123:500S
  7. Gudlaugsson O, Gillespie S, Lee K, et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis. 2003;37:1172
  8. Lipsett PA. Surgical critical care: Fungal infections in surgical patients. Crit Care Med. 2006;S215
  9. Csank C, Haynes K. Candida glabrata displays pseudohyphal growth. FEMS Microbiol Lett. 2000;189:115
  10. Fidel PL, Vazquez JA, Sobel JD. Candida glabrata: Review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev. 1999;12:80
  11. Brieland J, Essig D, Jackson C, et al. Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice. Infect Immun. 2001;69:5046
  12. Blot S, Vandewoude K, Hoste E, et al. Outcomes in critically ill patients with candidal fungemia: Candida albicans versus Candida glabrata. J Hosp Infect. 2001;47:308
  13. Hederwick SA, Lyons MJ, Liu M, et al. Epidemiology of yeast colonization in the intensive care unit. Eur J Clin Microbiol Infect Dis. 2000;19:663
  14. Burd RS, Raymond CS, Dunn DL. Endotoxin promotes synergistic lethality during concurrent Escherichia coli and Candida albicans infection. J Surg Res. 1992;52:537
  15. Klaerner HG, Uknis ME, Acton RD, et al. Candida albicans and Escherichia coli are synergistic pathogens during experimental microbial peritonitis. J Surg Res. 1997;70:161
  16. Akagawa G, Abe S, Yamaguchi H. Mortality of Candida albicans-infected mice is facilitated by superinfection of Escherichia coli or administration of its lipopolysaccharide. J Infect Dis. 1995;171:1539
  17. Goetz FW, Planas JV, MacKenzie S. Tumor necrosis factors. Dev Comp Immunol. 2004;28:487
  18. Spellberg B, Ibrahim AS, Edwards JE, et al. Mice with disseminated candidiasis die of progressive sepsis. J Infect Dis. 2005;192:336
  19. Bendel CM, Hess DJ, Garni RM, et al. Comparative virulence of Candida albicans yeast and filamentous forms in orally and intravenously inoculated mice. Crit Care Med. 2003;31:501
  20. In:  Winn W,  Allen S,  Janda W editor. Koneman's Color Atlas and Textbook of Diagnostic Microbiology. 6th ed.. Philadelphia: Lippincott: Williams and Wilkins; 2006;
  21. Odds FC, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol. 1994;32:1923
  22. Remick DG, Newcomb DE, Bolgos GL, et al. Comparison of the mortality and inflammatory response of two models of sepsis: Lipopolysaccharide versus cecal ligation and puncture. Shock. 2000;13:110
  23. Sundgren-Anderson A, Ostlund P, Bartfai T. IL-6 is essential in TNF-α induced fever. Am J Physiol. 1998;275:R2028
  24. van der Laan LJW, Dopp EA, Haworth R, et al. Regulation and functional involvement of macrophage scavenger receptor MARCO in clearance of bacteria in vivo. J Immunol. 1999;162:939
  25. Bopp LH, Baltch AL, Ritz WJ, et al. Antifungal effect of voriconazole on intracellular Candida glabrata, Candida krusei, and Candida parapsilosis in human monocyte-derived macrophages. J Med Microbiol. 2006;55:865
  26. Baltch AL, Bopp LH, Smith RP, et al. Effects of voriconazole, granulocyte-macrophage colony-stimulating factor, and interferon-γ on intracellular fluconazole-resistant Candida glabrata and Candida krusei in human monocyte-derived macrophages. Diagnot Microbiol Infect Dis. 2005;52:299
  27. Garcha UK, Brummer E, Stevens DA. Synergy of fluconazole with human monocytes or monocyte-derived macrophages for killing of Candida species. J Infect Dis. 1995;172:1620
  28. van der Graff CAA, Netea MG, Verschueren I, et al. Differential cytokine production and Toll-like receptor signaling pathways by Candida albicans blastoconidia and hyphae. Infect Immun. 2005;73:7458
  29. Murray RZ, Kay JG, Sangermani DG, et al. A role for the phagosome in cytokine secretion. Science. 2005;310:1492
  30. Steinshamn S, Waage A. Tumor necrosis factor and interleukin-6 in Candida albicans infection in normal and granulocytopenic mice. Infect Immun. 1992;60:4003
  31. Kielian TL, Blecha F. CD14 and other recognition molecules for lipopolysaccharide: A review. Immunopharmacology. 1995;29:187
  32. Vonk AG, Netea MG, van Krieken JH, et al. Delayed clearance of intraabdominal abscesses caused by Candida albicans in tumor necrosis factor-α- and lymphotoxin-α-deficient mice. J Infect Dis. 2002;186:1815
  33. Louie A, Baltch AL, Smith RP, et al. Tumor necrosis factor-α has a protective role in a murine model of systemic candidiasis. Infect Immun. 1994;62:2761

PII: S0022-4804(08)00486-1

doi: 10.1016/j.jss.2008.07.022

Journal of Surgical Research
Volume 155, Issue 2 , Pages 217-224 , August 2009

Article Tools

* Image Usage & Resolution